{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:36:13Z","timestamp":1791513373052,"version":"4.3.4"},"reference-count":19,"publisher":"BMJ","funder":[{"name":"Canadian Institutes of Health Research\u2019s Canada Graduate Research Scholarship - Doctoral (CGRS D) Program","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2026,8,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Time toxicity\u2014the time patients spend receiving treatment and associated care\u2014is an increasingly recognised burden of cancer treatment. Literature has largely relied on calendar-day\u2013based measurement, which may obscure meaningful variation in time burden. This study aimed to quantify time toxicity with greater granularity by measuring it in hours.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of patients with recurrent prostate cancer enrolled in a clinical trial of concurrent high-dose-rate brachytherapy and hormonal therapy at a tertiary cancer centre in Canada. Electronic medical records were reviewed for 180 days following treatment initiation. Time toxicity was quantified as median days and median hours per month spent in care. Subgroup analyses were conducted by encounter type. Sensitivity analyses incorporated the estimated travel time. Type I error was 0.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>46 patients were included. Patients had a median of 6 healthcare encounters: 3 in Month 1, with the remaining 3 distributed across the following 5 months. Early encounters were predominantly treatment-related, whereas later encounters were largely monitoring or follow-up appointments. The median time toxicity was 13.7 hours over 6 months following treatment initiation, with 10.9 hours occurring in Month 1 and minimal time in subsequent months. Planned, in-person encounters accounted for nearly all toxicity. Incorporating travel time more than doubled time toxicity in sensitivity analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Time toxicity was front-loaded and driven primarily by planned, in-person care. Expressing time toxicity in hours provided clearer quantification of early time burden. More granular, patient-centred measurement of time toxicity should be prioritised in future cancer trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2026-006361","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:20:22Z","timestamp":1786728022000},"page":"spcare-2026-006361","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Time toxicity in patients receiving brachytherapy and hormonal therapy for recurrent prostate cancer: a cohort study"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6195-8624","authenticated-orcid":false,"given":"Ronald","family":"Chow","sequence":"first","affiliation":[{"name":"Centre for Evidence-Based Medicine, University of Oxford, Oxford, UK"},{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bayrakdarian","sequence":"additional","affiliation":[{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-0244","authenticated-orcid":false,"given":"Camilla","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia C","family":"Richards","sequence":"additional","affiliation":[{"name":"Department of Analytical, Environmental and Forensic Science, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Heneghan","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Leigh","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Chung","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"2026081410201560000_spcare-2026-006361v1.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2026081410201560000_spcare-2026-006361v1.2","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v12.i3.150"},{"key":"2026081410201560000_spcare-2026-006361v1.3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1200\/JCO.2017.74.7907","article-title":"The Toxicity of Time","volume":"36","author":"Daily","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026081410201560000_spcare-2026-006361v1.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02810"},{"key":"2026081410201560000_spcare-2026-006361v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2025-006038"},{"key":"2026081410201560000_spcare-2026-006361v1.6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"2026081410201560000_spcare-2026-006361v1.7","unstructured":"Chow R , Chung H , Leigh J . Development and validation of a chart-based tool for quantifying time toxicity in cancer pharmacologic clinical trials. 2026. Available: https:\/\/osf.io\/zg9v7\/overview"},{"key":"2026081410201560000_spcare-2026-006361v1.8","unstructured":"Amin MB , Edge SB , Greene FL , et al . AJCC Cancer Staging Manual. 8th edn. New York, NY: Springer, 2017."},{"key":"2026081410201560000_spcare-2026-006361v1.9","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198212000-00014"},{"key":"2026081410201560000_spcare-2026-006361v1.10","doi-asserted-by":"publisher","DOI":"10.1007\/BF03403824"},{"key":"2026081410201560000_spcare-2026-006361v1.11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5194\/isprs-archives-XLVIII-4-W7-2023-53-2023","article-title":"A Comparative Study Of Methods For Drive Time Estimation On Geospatial Big Data: A Case Study In USA","volume":"XLVIII-4\/W7-2023","author":"Fu","year":"2023","journal-title":"Int Arch Photogramm Remote Sens Spatial Inf Sci"},{"key":"2026081410201560000_spcare-2026-006361v1.12","unstructured":"Canada Bo . Annual average exchange rates. 2021. Available: https:\/\/www.bankofcanada.ca\/rates\/exchange\/annual-average-exchange-rates\/"},{"key":"2026081410201560000_spcare-2026-006361v1.13","doi-asserted-by":"crossref","first-page":"e859","DOI":"10.1200\/OP.22.00737","article-title":"Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial","volume":"19","author":"Gupta","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"2026081410201560000_spcare-2026-006361v1.14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/jnci\/djae077","article-title":"The association of health-care contact days with physical function and survival in CCTG\/AGITG CO.17","volume":"116","author":"Gupta","year":"2024","journal-title":"JNCI"},{"key":"2026081410201560000_spcare-2026-006361v1.15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/oncolo\/oyad128","article-title":"Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial","volume":"28","author":"Gupta","year":"2023","journal-title":"Oncologist"},{"key":"2026081410201560000_spcare-2026-006361v1.16","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102046","article-title":"Time toxicity associated with early phase clinical trial participation","volume":"8","author":"Nindra","year":"2023","journal-title":"ESMO Open"},{"key":"2026081410201560000_spcare-2026-006361v1.17","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/OP.23.00811","article-title":"Time Toxicity Experienced by Early-Phase Cancer Clinical Trial Participants","volume":"20","author":"Durbin","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"2026081410201560000_spcare-2026-006361v1.18","doi-asserted-by":"crossref","unstructured":"Chow R , Im JHB , Richards GC , et al . n.d. Financial toxicity of patients with cancer enrolled in clinical trials: a systematic review. BMJ Support Palliat Care 2026:spcare\u20132025. doi:10.1136\/spcare-2025-005976","DOI":"10.1136\/spcare-2025-005976"},{"key":"2026081410201560000_spcare-2026-006361v1.19","unstructured":"Canada S . Median total income, by census family type, annual. 2021. Available: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1110022201"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2026-006361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:20:23Z","timestamp":1786728023000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2026-006361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":19,"alternative-id":["10.1136\/spcare-2026-006361"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2026-006361","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}